Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance.
about
Tacrolimus (FK506) for induction of remission in refractory ulcerative colitisNew developments in the treatment of inflammatory bowel disease.Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease.European evidence based consensus on the diagnosis and management of Crohn's disease: current management.Drug safety in the treatment of Crohn's disease.Review article: practical management of inflammatory bowel disease patients taking immunomodulators.Basic immunosuppressive drugs outside solid organ transplantation.Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD.Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease.Drug safety in Crohn's disease therapy.Management of Crohn's disease from efficacy, quality of life and health economic perspectives.Review article: the role of non-biological drugs in refractory inflammatory bowel disease.Practical application of anti-TNF therapy for luminal Crohn's disease.Novel topical therapies for distal colitis.Systematic review: the role of tacrolimus in the management of Crohn's disease.What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?Oral tacrolimus for the treatment of refractory inflammatory bowel disease in the biologic era.Successful therapy of refractory pyoderma gangrenosum and periorbital phlegmona with tacrolimus (FK506) in ulcerative colitis.Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn's disease: a pilot study.
P2860
Q24242681-A5CBA615-5AAE-4C2F-A2D8-D58F1BD84798Q34544666-5C3F3381-974C-4766-A90C-DCA9F79BF18DQ34554247-B728C5F7-4EA8-4154-ACC4-128A5D659E00Q34564902-6179BA39-49C8-46EA-ABA2-3E692DB086F0Q36041692-1601C932-B8C1-4E95-8368-9E027EECA33CQ36166363-0CA8C6E0-58B3-4485-8DC6-0E0B2BE0361DQ36407314-418AADF3-EBD4-40BF-A37D-3B032223E362Q36457546-3D53CB22-8A1E-47DC-A478-061C593271E4Q36700682-6F76ED08-AFCC-4AF2-B480-EC1A16886434Q37073426-4912D58F-68F4-432D-A509-954BCEF40DEFQ37609246-EC5440AF-56C5-41EA-B64B-F090BE0D0BD3Q37817487-8F86780B-D827-406B-918A-E00527EDDD3AQ37845327-D7BF23E1-0267-4148-9342-CD74E0505D38Q37876204-735110CA-C97B-4037-BC3C-0FCE03B604ADQ37945747-83EE8420-B6F0-4918-A541-1F11FCCE5E60Q38191583-B2E01970-C90E-4A4A-A663-2F08CDB313D9Q43497300-6FB90E47-75F7-447D-8336-D369E7773332Q45099634-6236A2E1-653A-4AFA-A69F-619F87C9F559Q45240451-724AC9D2-17DF-428B-BD46-D79E7899BF83
P2860
Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Oral tacrolimus long-term ther ...... isease and steroid resistance.
@ast
Oral tacrolimus long-term ther ...... isease and steroid resistance.
@en
type
label
Oral tacrolimus long-term ther ...... isease and steroid resistance.
@ast
Oral tacrolimus long-term ther ...... isease and steroid resistance.
@en
prefLabel
Oral tacrolimus long-term ther ...... isease and steroid resistance.
@ast
Oral tacrolimus long-term ther ...... isease and steroid resistance.
@en
P2093
P2860
P1476
Oral tacrolimus long-term ther ...... isease and steroid resistance.
@en
P2093
Francavilla A
Francavilla R
Guglielmi FW
Ingrosso M
Principi M
P2860
P304
P356
10.1046/J.1365-2036.2001.00938.X
P407
P577
2001-03-01T00:00:00Z